Raab & Moskowitz Asset Management LLC Gilead Sciences, Inc. Transaction History

Raab & Moskowitz Asset Management LLC

$367 Million
Q2 2024

A detailed history of Raab & Moskowitz Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 4,297 shares of GILD stock, worth $378,479. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,297

Previous 4,447 3.37%

Holding current value

$378,479

Previous $325,000 9.54%

% of portfolio

0.08%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$63.15 - $72.88 $9,472 - $10,932	-150 Reduced 3.37%	4,297 $294,000
Q4 2023 Feb 02, 2024	SELL	$73.27 - $83.09 $17,804 - $20,190	-243 Reduced 5.18%	4,447 $360,000
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $12,939 - $14,117	175 Added 3.88%	4,690 $351,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $7,731 - $8,808	-100 Reduced 2.17%	4,515 $374,000
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $4,237 - $6,083	68 Added 1.5%	4,615 $0
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $4,048 - $4,624	-68 Reduced 1.47%	4,547 $280,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $3,924 - $4,420	68 Added 1.5%	4,615 $285,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $3,244 - $3,682	-50 Reduced 1.09%	4,547 $330,000
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $33,845 - $36,515	-500 Reduced 9.81%	4,597 $321,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $2,475 - $2,704	-39 Reduced 0.76%	5,097 $351,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $15,180 - $17,320	253 Added 5.18%	5,136 $331,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $14,332 - $16,331	-253 Reduced 4.93%	4,883 $284,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $8,880 - $11,165	143 Added 2.86%	5,136 $324,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $11,502 - $13,356	-159 Reduced 3.09%	4,993 $384,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $2,943 - $3,770	-47 Reduced 0.9%	5,152 $385,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $5,299 - $5,829	-86 Reduced 1.63%	5,199 $337,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $12,001 - $13,248	192 Added 3.77%	5,285 $334,000
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $24,748 - $27,752	-400 Reduced 7.28%	5,093 $344,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $44,557 - $58,144	-736 Reduced 11.82%	5,493 $343,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $24,734 - $27,385	-347 Reduced 5.28%	6,229 $480,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $329,590 - $384,454	-5,080 Reduced 43.58%	6,576 $465,000
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $68,469 - $83,472	-940 Reduced 7.46%	11,656 $878,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $91,427 - $107,323	-1,285 Reduced 9.26%	12,596 $902,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $41,463 - $49,145	-575 Reduced 3.98%	13,881 $1.04 Million
Q2 2017 Aug 16, 2017	BUY	N/A	14,456	14,456 $1.05 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.

Account

Raab & Moskowitz Asset Management LLC Gilead Sciences, Inc. Transaction History